Taurine provides neuroprotection against retinal ganglion cell degeneration.

Retinal ganglion cell (RGC) degeneration occurs in numerous retinal diseases leading to blindness, either as a primary process like in glaucoma, or secondary to photoreceptor loss. However, no commercial drug is yet directly targeting RGCs for their neuroprotection. In the 70s, taurine, a small sulf...

Full description

Bibliographic Details
Main Authors: Nicolas Froger, Lucia Cadetti, Henri Lorach, Joao Martins, Alexis-Pierre Bemelmans, Elisabeth Dubus, Julie Degardin, Dorothée Pain, Valérie Forster, Laurent Chicaud, Ivana Ivkovic, Manuel Simonutti, Stéphane Fouquet, Firas Jammoul, Thierry Léveillard, Ryad Benosman, José-Alain Sahel, Serge Picaud
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3480351?pdf=render